BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 16957768)

  • 41. Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo.
    Sarti M; Sevignani C; Calin GA; Aqeilan R; Shimizu M; Pentimalli F; Picchio MC; Godwin A; Rosenberg A; Drusco A; Negrini M; Croce CM
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):806-13. PubMed ID: 15701871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
    Kim EH; Kim HS; Kim SU; Noh EJ; Lee JS; Choi KS
    Oncogene; 2005 Oct; 24(46):6877-89. PubMed ID: 16007142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model.
    Bartholomeusz C; Itamochi H; Yuan LX; Esteva FJ; Wood CG; Terakawa N; Hung MC; Ueno NT
    Cancer Res; 2005 Sep; 65(18):8406-13. PubMed ID: 16166319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics.
    McManus DC; Lefebvre CA; Cherton-Horvat G; St-Jean M; Kandimalla ER; Agrawal S; Morris SJ; Durkin JP; Lacasse EC
    Oncogene; 2004 Oct; 23(49):8105-17. PubMed ID: 15378029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro.
    Connolly K; Mitter R; Muir M; Jodrell D; Guichard S
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):307-16. PubMed ID: 19034449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
    Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of caspase inhibitors for limiting death in mammalian cell culture.
    Sauerwald TM; Oyler GA; Betenbaugh MJ
    Biotechnol Bioeng; 2003 Feb; 81(3):329-40. PubMed ID: 12474256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-specific expression of X-linked inhibitor of apoptosis in the anterior pituitary of streptozotocin-induced diabetic rats.
    Arroba AI; Lechuga-Sancho AM; Frago LM; Argente J; Chowen JA
    J Endocrinol; 2007 Jan; 192(1):215-27. PubMed ID: 17210759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells.
    Lippa MS; Strockbine LD; Le TT; Branstetter DG; Strathdee CA; Holland PM
    Apoptosis; 2007 Aug; 12(8):1465-78. PubMed ID: 17440816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
    Chovolou Y; Wätjen W; Kampkötter A; Kahl R
    Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The novel phospholipase C activator, m-3M3FBS, induces apoptosis in tumor cells through caspase activation, down-regulation of XIAP and intracellular calcium signaling.
    Jung EM; Lee TJ; Park JW; Bae YS; Kim SH; Choi YH; Kwon TK
    Apoptosis; 2008 Jan; 13(1):133-45. PubMed ID: 18060503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
    Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
    Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells.
    Glaser T; Wagenknecht B; Groscurth P; Krammer PH; Weller M
    Oncogene; 1999 Sep; 18(36):5044-53. PubMed ID: 10490841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo.
    Kang CS; Zhang ZY; Jia ZF; Wang GX; Qiu MZ; Zhou HX; Yu SZ; Chang J; Jiang H; Pu PY
    Cancer Gene Ther; 2006 May; 13(5):530-8. PubMed ID: 16410821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
    Lamfers ML; Gianni D; Tung CH; Idema S; Schagen FH; Carette JE; Quax PH; Van Beusechem VW; Vandertop WP; Dirven CM; Chiocca EA; Gerritsen WR
    Cancer Res; 2005 Oct; 65(20):9398-405. PubMed ID: 16230403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
    Gondi CS; Lakka SS; Yanamandra N; Siddique K; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2003 Sep; 22(38):5967-75. PubMed ID: 12955075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.
    Mohr A; Albarenque SM; Deedigan L; Yu R; Reidy M; Fulda S; Zwacka RM
    Stem Cells; 2010 Nov; 28(11):2109-20. PubMed ID: 20882532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.